Gregory P Licholai Net Worth & Insider Trades

Gregory P Licholai - VP, Amicus Therapeutics Inc

As of February 5, 2009

What is Gregory P Licholai's Net Worth?

The current estimated net worth of Amicus Therapeutics Inc's VP, Gregory P Licholai, is estimated to be about $641.54K . Gregory P Licholai owns about 152 units of Amicus Therapeutics Inc common stock. In the last year at Amicus Therapeutics Inc, Gregory P Licholai has sold an estimated value of $415.3K worth.

What is Gregory P Licholai's Past Insider Trading?

Gregory P Licholai's largest purchase order was 15,000 units , worth over $9.56K on July 17, 2008. Gregory P Licholai's largest sale order was 15,000 units , worth over $195K on July 17, 2008. In total, Gregory P Licholai has made about 6 transactions over a year of their time at Amicus Therapeutics Inc. Gregory P Licholai usually trades in February, with the busiest year in 2008. The most recent transaction was a sale order of 1,401 units , worth over $21.16K on August 20, 2008.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Gregory P Licholai's' Mailing Address?

  • Mailing address is C/o Amicus Therapeutics, Inc. 6 Cedar Brook Drive Cranbury NJ 08512 NJ

Amicus Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
John F. Crowley 2020 $719,514 $514,800 $5,479,971 $2,492,491 $1,282,843 $825,505 $11,315,124
John F. Crowley 2019 $656,770 $476,815 $5,327,948 $2,334,850 $234,775 $821,505 $9,852,663
John F. Crowley 2018 $637,640 $445,710 $3,861,699 $1,654,347 - $820,567 $7,419,963
Daphne Quimi 2020 $45 $228,712 $1,534,382 $697,894 - $34,639 $2,947,
Daphne Quimi 2019 $400,000 $212,960 $1,311,492 $538,808 - $17,487 $2,480,747
Daphne Quimi 2018 - - - - - - -
Bradley L. Campbell 2020 $515, $368,872 $2,557,304 $1,163,159 - $33,694 $4,
Bradley L. Campbell 2019 $500,877 $378,788 $2,254,114 $987,822 - $19,538 $4,141,139
Bradley L. Campbell 2018 $468,109 $327,209 $1,411,802 $604,817 - $16,710 $2,828,646
Hung Do 2020 $42 $187,908 $1,461,322 $664,660 - $31,248 $2,772,106
Hung Do 2019 $414,625 $200,678 $1,393,462 $574,732 - $22,129 $2,605,626
Hung Do 2018 - - - - - - -
Ellen S. Rosenberg 2020 $452, $199,051 $1,461,322 $664,660 $87,751 $20,748 $2,885,820
Ellen S. Rosenberg 2019 $439,213 $233,837 $1,393,462 $610,648 - $13,538 $2,690,698
Ellen S. Rosenberg 2018 $426,420 $208,647 $996,591 $426,933 - $18,270 $2,076,862
Jay Barth 2020 $366,269 - $1,315,184 $598,197 - $641,306 $2,920,956
Jay Barth 2019 $471,621 $228,265 $1,229,522 $538,808 - $15,998 $2,484,214
Jay Barth 2018 $457,885 $192,037 $996,591 $426,933 - $18,790 $2,092,236
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm

What are Amicus Therapeutics Inc's Past Insider Trades?

Amicus Therapeutics Inc's most recent insider trade came on August 17, 2022 by John Crowley who sold 10,468 units worth $128.58K . In the last 15 years, insiders at Amicus Therapeutics Inc have sold an estimated value of $174.96M and bought an estimated value of $192.08M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Executive Chairman,  Bradley Campbell, President & CEO,  and James N Topper, Director .

AMICUS THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1